SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950170-24-007483
Filing Date
2024-01-25
Accepted
2024-01-25 17:00:09
Documents
1
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 3/A ownership.html 3/A  
1 3/A ownership.xml 3/A 2982
  Complete submission text file 0000950170-24-007483.txt   4501
Mailing Address OMTHERA PHARMACEUTICALS, INC. 707 STATE ROAD PRINCETON NJ 08540
Business Address
Davidson Michael H. (Reporting) CIK: 0001573785 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41562 | Film No.: 24563043

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)